Inogen (INGN) vs Nyxoah SA (NYXH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Inogen (INGN) has outperformed Nyxoah SA (NYXH) over the past year, losing 31.6% versus a loss of 78.7%. Over five years, INGN leads with a -85.4% price change compared with -94.7% for NYXH. Inogen is the larger company by market cap ($164.0 million vs $138.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INGN | NYXH |
|---|---|---|
| Share price | $6.18 | $1.36 |
| Market cap | $164.01M | $138.50M |
| 1-day change | +4.04% | +0.74% |
| YTD return | -11.61% | -70.43% |
| 1-year return | -31.65% | -78.72% |
| 5-year return | -85.45% | -94.67% |
| EPS (TTM) | $-0.92 | $-2.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.13 | $6.60 |
| 52-week low | $5.05 | $1.26 |
| Distance from 52-week high | -32.31% | -79.39% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +94.17% | +208.82% |
| Average volume | 297.16K | 276.69K |
| Shares outstanding | 26.54M | 101.84M |
| Employees | 753 | 153 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INGN has outperformed NYXH by 47.1 percentage points over the past year.
About Inogen
INGN stock →Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Health Care · Industrial Specialties · 753 employees
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
INGN vs NYXH FAQ
Which is bigger, Inogen or Nyxoah SA?
Inogen (INGN) is larger, with a market capitalization of $164.01M compared with $138.50M for Nyxoah SA (NYXH).
Which stock has performed better over the past year, INGN or NYXH?
INGN returned -31.65% over the past 12 months, compared with -78.72% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Inogen and Nyxoah SA in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Inogen and Medical/Dental Instruments for Nyxoah SA.